Clinical Trials Logo

Clinical Trial Summary

Osmotherapy has been used as the medical treatment for brain edema and intracranial hypertension in critically brain injured patients. Measurement of serum osmolality during osmotherapy is of clinical importance to determine clinical efficacy, adjust dosage and avoid side effect. Serum osmolality is often measured in laboratory by cryoscopic technique as the reference method. However, in clinical setting, routine measurement of serum osmolality is not feasible at bedside, either in intensive care unit (ICU) or neurosurgical ward. Therefore, clinicians usually estimate serum osmolality by using equations derived from serum osmoles that can be measured by bedside blood gas analysis or routine laboratory chemical analysis, such as sodium, potassium, urea, and glucose. In present study, mannitol or hypertonic saline will be used in patients after craniotomy, and serum osmolality will be measured before and during drug infusion. Investigators hypothesize that the correlation of measured and calculated serum osmolality is better during infusion of hypertonic saline than mannitol.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)


Related Conditions & MeSH terms


NCT number NCT02037815
Study type Interventional
Source Capital Medical University
Contact
Status Completed
Phase Phase 4
Start date January 2014
Completion date June 2014

See also
  Status Clinical Trial Phase
Completed NCT00409058 - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI N/A
Completed NCT03323580 - Effects of Intraoperative GDFT on the Postoperative Brain Edema N/A
Completed NCT02368366 - Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI N/A
Not yet recruiting NCT04623307 - Non-contact DCS-Speckle Multi-parameter Imaging for Neurological Diseases
Completed NCT00088166 - XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors Phase 3
Completed NCT04311359 - A Pharmacovigilance Study of Brain Oedema
Completed NCT03957837 - Optical Nerve Sheath Changes During Head Down Laparoscopy
Completed NCT02701582 - Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients N/A
Not yet recruiting NCT06307743 - Rapid Local Ischemic Postconditioning in Acute Ischemic Stroke N/A
Completed NCT03573999 - Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation Phase 4
Terminated NCT01369121 - Tolerability Study of Xerecept® in Pediatric Patients Phase 1/Phase 2
Completed NCT05070182 - Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)
Completed NCT00226655 - An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies Phase 3
Terminated NCT02320955 - Swiss Prospective Autologous Bone Flap Resorption Study
Completed NCT02594137 - A Comparison Between Two Techniques for Performing Decompressive Craniectomy N/A
Withdrawn NCT00226668 - XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema Phase 3
Terminated NCT01054404 - Furosemide vs Placebo for Brain Relaxation N/A
Recruiting NCT05622461 - Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery N/A
Completed NCT06327737 - Diabetic Ketoacidosis Diagnosis and Management
Not yet recruiting NCT06017635 - Non-invasive Monitoring and Serum Marker Study in Children With Cerebral Edema